menu
    • menu

    Company profile for Eirion Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. ("Haohai") that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion's products for the territory of China in exchange for an upfront payment in the amount of $8 million. The deal ...
    Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with Shanghai Haohai Biological Technology Ltd. ("Haohai") that will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eirion's products for the territory of China in exchange for an upfront payment in the amount of $8 million. The deal is structured in segments over the next approximately 18 months.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eirion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25-K Olympia Avenue | Suite 200 Woburn, MA 01801
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.eirionthera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eirion Therapeutic to Present at 2025 AAD Innovation Academy Meet
    Eirion Therapeutic to Present at 2025 AAD Innovation Academy Meet

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-to-present-at-the-2025-american-academy-of-dermatology-innovation-academy-meeting-302492376.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Eirion Therapeutics to present at 2025 AAD Innovation Academy
    Eirion Therapeutics to present at 2025 AAD Innovation Academy

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-to-present-at-the-2025-american-academy-of-dermatology-innovation-academy-meeting-302492376.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Eirion Reveals Breakthrough Hair Loss Treatment in Clinical Trial
    Eirion Reveals Breakthrough Hair Loss Treatment in Clinical Trial

    08 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-announces-potential-breakthrough-treatment-for-hair-loss-based-on-first-in-man-clinical-trial-results-302344730.html

    PR NEWSWIRE
    08 Jan 2025
    Share Share
    Eirion Reports AI-09 Trial Results for Injectable Neuromodulator
    Eirion Reports AI-09 Trial Results for Injectable Neuromodulator

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-announces-results-of-first-in-human-clinical-trial-evaluating-ready-to-use-liquid-injectable-neuromodulator-ai-09-for-the-treatment-of-wrinkles-302263722.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    Eirion Therapeutics to Present at the 2024 IMCAS WORLD CONGRESS
    Eirion Therapeutics to Present at the 2024 IMCAS WORLD CONGRESS

    02 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-to-present-at-the-2024-imcas-world-congress-302050783.html

    PR NEWSWIRE
    02 Feb 2024
    Share Share
    Eirion Therapeutics to Participate in the 2023 IMCAS WORLD CONGRESS
    Eirion Therapeutics to Participate in the 2023 IMCAS WORLD CONGRESS

    26 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-to-participate-in-the-2023-imcas-world-congress-301729384.html

    PR NEWSWIRE
    26 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search